Which best describes you?
-
A patient or
carer of a patient -
-
myAZmed has been created for people who use AZ medicines. If that’s not you but you’d like to learn more about AstraZeneca, please click here.
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
Which type of AZ medicine are you here to learn more about today?
-
Inhaler
An inhaler device helps medicine go straight into your lungs when you breathe in.
-
Injection
An injection allows medicine to be given using a needle and a syringe, or a pen device.
-
Tablet
Tablets, pills and capsules allow medicine to be swallowed and absorbed by your digestive tract.
-
Sachet
Sachets contain a powder that can be mixed with water for oral suspension, which allows the medicine to be taken as a drink to pass through your digestive tract
This website is not a substitute for the Patient Information Leaflet (PIL) that is provided with your Astrazeneca medicine. Please read the PIL before you start treatment.
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
Which type of inhaler have you been prescribed?
-
Symbicort®
(budesonide/formoterol fumarate dihydrate)
-
Trixeo Aerosphere®
(formoterol fumarate dihydrate/ glycopyrronium/ budesonide)
-
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
Which type of injection have you been prescribed?
-
Fasenra®
(benralizumab)
-
Tezspire®▼
(tezepelumab)
-
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.
Which type of tablet have you been prescribed?
-
Forxiga®
(dapagliflozin)
-
Lynparza®
(olaparib)
-
Tagrisso®
(osimertinib)
-
Truqap®▼
(capivasertib)
-
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.
Click on the medicine that matches yours
-
Symbicort® Turbohaler® 100/6
(budesonide/formoterol fumarate dihydrate)
-
Symbicort® Turbohaler® 200/6
(budesonide/formoterol fumarate dihydrate)
-
Symbicort® Turbohaler® 400/12
(budesonide/formoterol fumarate dihydrate)
-
Symbicort® pMDI 100/3
(budesonide/formoterol fumarate dihydrate)
-
Symbicort® pMDI 200/6
(budesonide/formoterol fumarate dihydrate)
-
Approval ID: GB-72511 Date of preparation: December 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.
Click on the medicine that matches yours
-
Trixeo Aerosphere®
(formoterol fumarate dihydrate/ glycopyrronium/ budesonide)
-
Approval ID: GB-72341 Date of Preparation: November 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
Click on the medicine that matches yours
-
Fasenra® 30mg solution for injection in pre-filled pen
(benralizumab)
-
Fasenra® 30mg solution for injection in pre-filled syringe
(benralizumab)
-
Who is the medicine for?
-
Adult
(18 years +)
-
Child
(10 to 17 years)
Approval ID: GB-57318 Date of preparation: July 2024
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.
I can't find my AZ medicine
If you can't see your AZ medicine on myAZmed, this may be because it hasn't been added yet.
Thank you for your patience while you wait for your medicine to be featured.
In the meantime, if you have questions about an AZ medicine that you have been prescribed, please contact your doctor, nurse or pharmacist.
You can also call AstraZeneca's UK-based Medical Information Team on: 0800 783 0033. Lines are open Monday to Friday, from 9am to 5pm.
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
I can't find my AZ medicine
If you can't see your AZ medicine on myAZmed, this may be because it hasn't been added yet.
Thank you for your patience while you wait for your medicine to be featured.
In the meantime, if you have questions about an AZ medicine that you have been prescribed, please contact your doctor, nurse or pharmacist.
You can also call AstraZeneca's UK-based Medical Information Team on: 0800 783 0033. Lines are open Monday to Friday, from 9am to 5pm.
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of medicines.
Side effects can also be reported to AstraZeneca in the following ways:
Online https://contactazmedical.astrazeneca.com
Email Medical.InformationUK@astrazeneca.com
Telephone 0800 783 0033
Click on the medicine that matches yours
-
Bydureon® 2 mg prolonged-release suspension for injection in pre-filled pen
(exenatide)
-
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of medicines.
Side effects can also be reported to AstraZeneca in the following ways:
Online https://contactazmedical.astrazeneca.com
Email Medical.InformationUK@astrazeneca.com
Telephone 0800 783 0033
Click on the medicine that matches yours
-
Forxiga® film-coated tablets
(dapagliflozin)
-
Approval ID: GB-57318 Date of preparation: July 2024
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.
Click on the medicine that matches yours
-
Lynparza® film-coated tablets
(olaparib)
-
Approval ID: GB-64896 Date of preparation: June 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.
Which type of oral suspension have you been prescribed?
-
Lokelma®
(sodium zirconium cyclosilicate)
-
Approval ID: GB-69418 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.
Click on the medicine that matches yours
-
Lokelma®
(sodium zirconium cyclosilicate)
Powder for oral suspension
-
Approval ID: GB-73271 Date of preparation: January 2026
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.
Click on the medicine that matches yours
-
Truqap▼ film coated tablets
(capivasertib)
-
Approval ID: GB-67381 Date of preparation: September 2025
Reporting side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.
Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.
Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.
If you are a UK healthcare professional you will be taken to AZ UK Medical Information
Please confirm that you are happy to continue
Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.
